These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6852229)

  • 1. EEG profile of the anticonvulsant action of viloxazine in the rabbit.
    Tartara A; Bo P; Maurelli M; Savoldi F; Manzo L
    Farmaco Sci; 1983 Mar; 28(3):161-6. PubMed ID: 6852229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.
    Meignen J; Grognet A; Deniard MJ; Dalphrase F; Roux E; DeFeudis FV
    Gen Pharmacol; 1982; 13(5):381-91. PubMed ID: 6890919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavioral and radioreceptor analysis of viloxazine stereoisomers].
    Danchev ND; Rozhanets VV; Zhmurenko LA; Glozman OM; Zagorevskiĭ VA
    Biull Eksp Biol Med; 1984 May; 97(5):576-8. PubMed ID: 6326891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug induced changes of EEG vigilance and optimizing control behavior during car driving (author's transl)].
    Bente D; Chenchanna P; Scheuler W; Sponagel P
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1978 Jun; 9(2):61-73. PubMed ID: 97074
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of the antidepressant viloxazin on EEG and optimization of the system driver-vehicle-road (author's transl)].
    Bente D; Chenchanna P; Scheuler W; Sponagel P
    Arzneimittelforschung; 1978; 28(8):1308-10. PubMed ID: 582393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of viloxazine HCl and flurazepam when given alone and in combination on sleep EEG: a double-blind interaction study with normals.
    Wilson WH; Freemon FR; Ban TA; Petrie WM; Clinton CL
    Pavlov J Biol Sci; 1980; 15(2):68-73. PubMed ID: 7003517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidence for the central serotoninergic activity of viloxazine.
    Pawłowski L; Ruczyńska J; Wojtasik E
    Pol J Pharmacol Pharm; 1979; 31(4):261-9. PubMed ID: 523336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EEG and behavioural study on the excitatory properties of caffeine in rabbits.
    Popoli P; Sagratella S; Scotti de Carolis A
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):5-15. PubMed ID: 2895610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon.
    Meldrum BS; Anlezark GM; Adam HK; Greenwood DT
    Psychopharmacology (Berl); 1982; 76(3):212-7. PubMed ID: 6808538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol interactions with typical and atypical antidepressants.
    Tartara A; Formigli L; Crema F; Maurelli M; Perucca E; Marchioni E; Manzo L; Savoldi F
    Neurobehav Toxicol Teratol; 1985; 7(2):139-41. PubMed ID: 3923380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viloxazine and anticonvulsants.
    Trimble MR
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):193-4. PubMed ID: 3981188
    [No Abstract]   [Full Text] [Related]  

  • 12. Viloxazine as a betamimetic antidepressant drug.
    Bourin M; Ortega A; Larousse C
    Neuropsychobiology; 1987; 17(1-2):35-40. PubMed ID: 2819765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor analysis of spectral EEG-data. Models of application in pharmaco-elektroencephalography (author's transl)].
    Bente D
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1979 Dec; 10(4):207-13. PubMed ID: 119632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emovit and lonetil--behavioral and neurochemical studies].
    Val'dman AV; Danchev ND
    Eksp Med Morfol; 1983; 22(2):59-64. PubMed ID: 6321132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior analysis based on neurochemical mechanisms of action of viloxazine and mianserin].
    Danchev N; Rusakov D
    Eksp Med Morfol; 1989; 28(1):23-8. PubMed ID: 2743926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitro.
    Greenwood DT; Kemp JD; Middlemiss DN
    J Pharm Pharmacol; 1982 Jan; 34(1):38-41. PubMed ID: 6174722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological profile of ketanserin.
    Bo P; Patrucco M; Savoldi F
    Farmaco Sci; 1987 Feb; 42(2):91-9. PubMed ID: 3494632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of viloxazine on serum carbamazepine levels in epileptic patients.
    Pisani F; Narbone MC; Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Di Perri R
    Epilepsia; 1984 Aug; 25(4):482-5. PubMed ID: 6745218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of viloxazine on drug-metabolizing enzyme systems after a single administration].
    al-Rifai IM
    Eksp Med Morfol; 1982; 21(4):187-90. PubMed ID: 6759105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.